Syneron Medical Ltd
(ELOS)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2012 | 12-2011 | 09-2011 | 06-2011 | 03-2011 | |
| Cash Flows From Operating Activities | |||||
| Net Income | N/A | -51,750 | -43,600 | -3,460 | -2,710 |
| Depreciation Amortization | N/A | 10,040 | 7,760 | 5,160 | 2,420 |
| Other Working Capital | N/A | -8,640 | -5,430 | -6,660 | -7,210 |
| Other Operating Activity | 0 | 5,660 | 1,940 | -1,530 | 1,670 |
| Operating Cash Flow | $N/A | $-44,690 | $-39,330 | $-6,490 | $-5,830 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | -2,110 | -1,690 | -1,330 | -770 |
| Other Investing Activity | 0 | 42,760 | 25,120 | 5,390 | -2,650 |
| Investing Cash Flow | $N/A | $40,650 | $23,430 | $4,060 | $-3,420 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 0 | 1,820 | 1,050 | 1,000 | 140 |
| Financing Cash Flow | $N/A | $1,820 | $1,050 | $1,000 | $140 |
| Exchange Rate Effect | N/A | 700 | 860 | 390 | 60 |
| Beginning Cash Position | N/A | 63,820 | 63,820 | 63,820 | 63,820 |
| End Cash Position | N/A | 62,310 | 49,830 | 62,800 | 54,770 |
| Net Cash Flow | $N/A | $-1,500 | $-13,980 | $-1,010 | $-9,040 |
| Free Cash Flow | |||||
| Operating Cash Flow | N/A | -44,690 | -39,330 | -6,490 | -5,830 |
| Free Cash Flow | 0 | -44,690 | -39,330 | -6,490 | -5,830 |